Polymorphisms in cytotoxic T-lymphocyte associated antigen 4 gene does not affect scytotoxic T-lymphocyte associated antigen 4 levels in human papillomavirus-infected women with or without cervical cancer
| dc.contributor.author | Wagh, P | en_US |
| dc.contributor.author | Kulkarni, P | en_US |
| dc.contributor.author | Kerkar, S | en_US |
| dc.contributor.author | Warke, H | en_US |
| dc.contributor.author | Chaudhari, H | en_US |
| dc.contributor.author | Deodhar, K | en_US |
| dc.contributor.author | Rekhi, B | en_US |
| dc.contributor.author | Tongaonkar, H | en_US |
| dc.contributor.author | Mania-Pramanik, J | en_US |
| dc.date.accessioned | 2020-04-23T07:36:18Z | |
| dc.date.available | 2020-04-23T07:36:18Z | |
| dc.date.issued | 2018-06 | |
| dc.description.abstract | Background: Cervical cancer (CaCx) is the second most common cancer in Indian women. Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) + 49 AA polymorphism is known to be associated with CaCx. Current attempt is to use immunotherapy for the treatment of metastatic melanoma and metastatic castration-resistant prostate cancer, i.e., blocking of CTLA-4 using a fully human monoclonal CTLA-4 antibody to disrupt its inhibitory signal. This allows the CTLs to destroy the cancer cells. There is no information available on the soluble level of CTLA-4 on which the immunotherapy is targeted. This is specifically in Indian population including cases with CaCx. Objective: The aim of this study is to evaluate the levels of soluble CTLA-4 (sCTLA-4) in human papillomavirus (HPV)-infected women with or without CaCx and their association with the polymorphism at CTLA-4 + 49 A/G and CTLA-4 ?318 C/T genotypes. Materials and Methods: This is an exploratory case–control study involving two groups of HPV-infected women, the cases were with invasive CaCx and the control group was women with the healthy cervix. sCTLA-4 levels were measured using ELISA in 92 CaCx cases and 57 HPV-positive women with the healthy cervix. Results: Both cases and controls have similar sCTLA-4 levels. Comparison of CTLA-4 + 49A/G and ?318 C/T genotypes with sCTLA-4 levels among cases and control also did not show any statistically significant difference. Conclusion: The present study suggests sCTLA-4 levels are not affected by a polymorphism at + 49 A>G CTLA-4. Hence, levels of CTLA-4 are similar in both CaCx cases and control group. | en_US |
| dc.identifier.affiliations | Department of Infectious Diseases Biology, ICMR-National Institute for Research in Reproductive Health, Mumbai, Maharashtra, India | en_US |
| dc.identifier.affiliations | Department of Infectious Diseases Biology, ICMR-National Institute for Research in Reproductive Health, Mumbai, Maharashtra, India; Department of Urology, University of California, San Francisco, California, USA | en_US |
| dc.identifier.affiliations | Department of Gynecology and Obstetrics, Seth G. S. Medical College, KEM Hospital, Mumbai, Maharashtra, India | en_US |
| dc.identifier.affiliations | Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India | en_US |
| dc.identifier.affiliations | Department Urology and Gynecologic Oncology, Tata Memorial Hospital; Department of Surgery, Hinduja Hospital, Mumbai, Maharashtra, India | en_US |
| dc.identifier.citation | Wagh P, Kulkarni P, Kerkar S, Warke H, Chaudhari H, Deodhar K, Rekhi B, Tongaonkar H, Mania-Pramanik J. Polymorphisms in cytotoxic T-lymphocyte associated antigen 4 gene does not affect scytotoxic T-lymphocyte associated antigen 4 levels in human papillomavirus-infected women with or without cervical cancer. Indian Journal of Medical Microbiology. 2018 Jun; 36(2): 207-210 | en_US |
| dc.identifier.issn | 0255-0857 | |
| dc.identifier.issn | 1998-3646 | |
| dc.identifier.place | India | en_US |
| dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/198755 | |
| dc.language | en | en_US |
| dc.publisher | Indian Association of Medical Microbiologists | en_US |
| dc.relation.issuenumber | 2 | en_US |
| dc.relation.volume | 36 | en_US |
| dc.source.uri | https://dx.doi.org/10.4103/ijmm.IJMM_17_220 | en_US |
| dc.subject | Cervical cancer | en_US |
| dc.subject | polymorphism | en_US |
| dc.subject | soluble cytotoxic T-lymphocyte associated antigen 4 | en_US |
| dc.title | Polymorphisms in cytotoxic T-lymphocyte associated antigen 4 gene does not affect scytotoxic T-lymphocyte associated antigen 4 levels in human papillomavirus-infected women with or without cervical cancer | en_US |
| dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1